Krishna Sharan

Publications

• Research Article   
  Comparison of toxicities of three weekly and weekly cisplatin in concurrent chemoradiation for head and neck cancers a retrospective cohort study
  Author(s): Ciniraj Raveendran*, I Yadev, Krishna Sharan and Bejadi Vadhiraja
  
  Background & aims: Concurrent chemoradiation in Head and neck cancer patients offers a significant improvement in local control and overall survival at the expense of added toxicities. In practice, different schedules of Cisplatin are used with concurrent chemoradiation. This retrospective study aims to compare the toxicity profile of head and neck cancer patients treated with concurrent chemoradiation using three weekly cisplatin and weekly cisplatin. Methods: This is a retrospective cohort study that included patients with Head and Neck Cancers treated with concurrent chemoradiation with either of the two schedules of Cisplatin using 100 mg/m2 every three weeks or 40 mg/m2 every week. Conventional fields were used for radiation treatment. Treatment review charts were used to assess the toxicity of the treatment using RTOG toxicity grad.. Read More»
  

  Abstract HTML PDF